Cell Therapy News Volume 6.08 | Feb 10 2005

Tufts-NEMC Researchers Identify Enzyme that Activates Cancer Cell Growth and Invasion
Developing compounds to block activation pathway
Article

University of Toronto Team Discovers Stem Cell Jackpot
Umbilical jelly loaded with cells generates hope for tissue repair and transplants
Article

Rare Muscle-Forming Cells Found in Newborn Hearts
Scientists have identified rare stem cells in the hearts of newborns, which could be used to treat babies with cardiac problems
Article

Heart Cells Discovery Raises Treatment Hopes
Article

Child with Cerebral Palsy Who Could Not See or Speak Does Both Following Umbilical Cord Stem Cell Therapy
Article

Circles of DNA Might Help Predict Success of Stem Cell Transplantation
Article 1, Article 2

Stem Cells Implanted into Pancreas of Diabetic Patient through an Artery, Argentina
Article

University of Central Florida Stem Cell Research May Hold Promise for Treating Alzheimer’s Disease
A compound may improve the chances that stem cells transplanted from a patient’s bone marrow will help take over brain functions
Article

Details Discovered on How Human Stem Cells Become Nerve Cells in Research Funded by The ALS Association
Findings Suggest Routes to New Therapies for Lou Gehrig’s Disease
Article

Joslin Scientists Show Knocking Out Two Key Signals Will Cause Type 2 Diabetes
Article

Woman Donates Half of Pancreas to Aid Daughter With Type 1 Diabetes
Article

Inserting Corrective Genes into the Brain to Fight Parkinson’s Disease
Article

Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
Article

Vaccine Hopes for Blood Cancers
Article

India Begins HIV Vaccine Trials
Article

Possible Link Between CD36 & Sterile Inflammation May Lead to Autoimmune Therapies
Article

Self-Assembled Nano-Sized Probes Allow Penn Researchers To See Tumors Through Flesh And Skin
“It should also be possible to use an emissive polymersome vesicle to transport therapeutics directly to a tumor, enabling us to actually see if chemotherapy is really going to its intended target.”
Article

Study Suggests NovaBone May Stimulate New Bone Formation
Article

Dolly Scientist to Clone Embryos for Stem Cells
Article

ABSTRACT, REVIEWS, & SPECIAL REPORTS

In Vivo Cervical Cancer Growth Inhibition by Genetically Engineered Cytotoxic T Cells
Abstract

B Cell-directed Therapy in Rheumatoid Arthritis – Clinical Experience
Abstract

Human Mesenchymal Stem Cells Inhibit Differentiation and Function of Monocyte-derived Dendritic Cells
Abstract

Induction of Chondro-, Osteo- and Adipogenesis in Embryonic Stem Cells by Bone Morphogenetic Protein-2: Effect of Cofactors on Differentiating Lineages
Abstract

A Multiprong Approach to Cancer Gene Therapy by Coencapsulated Cells
Abstract

Prospective Clinical Trials of Biotherapies in Solid Tumors: A 5-year Survey
Abstract

The Human Fertilisation and Embryology Authority Grants Embryonic Stem Cell Research Licence to Study Motor Neuron Disease
Article

Call for £100m UK Stem Cell Fund
Leading UK scientists and entrepreneurs are calling for the creation of a charitable foundation to promote and fund stem cell research in Britain
Article

Massachusetts Senators File Bill for Stem Cell Research
Article

India: New Biotechnology Policy to Boost Research
Article

Amgen Confirms Decision to Halt GDNF Study
Article

Aastrom Biosciences Achieves Clinical Milestone in Its Phase I/II US Bone Graft Trial
Article

HemoGenix(TM) Announces the Release of the OxyFLOW(TM) Research Kit in Collaboration With Biotrin International Ltd. of Dublin, Ireland
Article

Baxter and Cerus Sign New Agreement to Commercialize INTERCEPT Blood System
Article

BioE, Inc. Receives $8.3 Million In Funding From Private Investors; Company’s Pioneering Stem Cell Separation Technology Continues To Fuel Interest Among Investment Community
Article

Biolex And Medarex Sign Research Collaboration Agreement
Article

Genzyme Acquires Verigen AG, Bolstering Global Orthopaedic Franchise
Article

M.D. Anderson Grants Exclusive License to Quest Diagnostics
Article

Medtronic, Alnylam to Collaborate on Neurodegenerative Treatments
Article

NeoGenomics Announces Entry Into Flow Cytometry Testing Market
Article

Robarts Research Institute Loses Stem Cell Star
After two years in London, Dr. Melissa Carpenter is returning to California
Article

Smith & Nephew Explores Stem Cell Bone Repair
Article

Vertebron Inc. Announces the Release of Its First Allograft, VERTEBRON PLF Allograft System, and Its Ability to Provide Complete Lumbar Spine Solutions
Article

MARKET REPORTS

Malachite Management has joined forces with established and reputable authors and publishers to bring you the following market reports outlining the very latest in Cell Therapy, Gene Therapy and Immunotherapeutic Approaches to Cancer. 

“Cell Therapy – Technologies, Markets, and Companies” is over 400 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the cell therapy industry worldwide.For more information and to order see:

Cell Therapy Report Summary
Cell Therapy Sample Chapter
Cell Therapy Table of Contents Vol. 1 Vol. 2
Cell Therapy Order Form

“Gene Therapy – Technologies, Markets, and Companies” is over 500 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the gene therapy industry worldwide.
For more information, including order forms, please see:

Gene Therapy Report Summary
Gene Therapy Table of Contents Vol. 1  Vol. 2
Gene Therapy Order Form

The Immunotherapy Reports cover the most recent developments in the immunotherapeutic approaches to cancer.

A Shift in Cancer Immunotherapy Strategies?
Immunotherapy Strategies Executive Summary
Immunotherapy Strategies Table of Contents

Future Perspectives in Cancer Immunotherapy
Future Perspectives Executive Summary
Future Perspectives Table of Contents

Immunotherapy Reports Order Form

NATIONAL INSTITUTES OF HEALTH

NIH Guide for Grants and Contracts – Week Of February 11, 2005
Link

NHLBI Competitive Supplements For Human Embryonic Stem Cell Research
Link

Registration Deadlines for 2005 Regional Seminars in Program Funding and Grants Administration
Link

Clinical Outcomes of Live Organ Donors (RFA)
Link

Protein Biomarkers of Infection-Associated Cancers
Link

The National Heart, Lung, and Blood Institute Hosts Red Dress Collection 2005 Fashion Show on National Wear Red Day
Link

How to Conduct Non-Federal Stem Cell Research Without Violating the Federal Stem Cell Funding Prohibition
Link

NIH Human Embryonic Stem Cell Registry
The Registry lists the derivations of stem cells that are eligible for federal funding.
The purpose of the Registry is to provide investigators with:
-a unique NIH Code for each cell line that must be used when applying for NIH funding and
-contact information to facilitate investigators’ acquisition of stem cells.
Link

International HapMap Consortium Expands Mapping Effort
Link

The Shapes of Life: NIGMS Project Yields More Than 1,000 Protein Structures
Link

All new CBER information can be reached from the What’s New page

Licensed Products and Establishments List – Update
Link

Approved Biologics NDA and ANDA Applications – Update
Link

Cleared Biologics 510(k) Device Applications – Update
Link

2005 Clinical Hold / Refusal to File Meeting Schedule
Link

Recall of Rapid HIV Test Kits – Globus Media, Inc
Link

Annual Comprehensive List of Guidance Documents at the Food and Drug Administration; Correction
Link

For Country-Specific & International Regulatory Resources, Including Links to Regulatory Agencies Such as the FDA, EMEA, & More Click Here

UNITED STATES
FDA

FDA Proposes $1.9 Billion Budget for Fiscal 2006
Link

ICH Draft Guidance on S8 Immunotoxicity Studies for Human Pharmaceuticals
Link

FDA Approves Feasibility Study for Ventracor Heart Device in U.S.
Link

Blood Products Advisory Committee; Notice of Meeting
Link

JOB POSTINGS IN CELL THERAPY NEWS ARE FREE!
For information on posting an opportunity email: info@connexoncreative.com

JOB POSTINGS

Acting President  NEW!
San Diego, California (California Institute of Regenerative Medicine)

Cellular Production Lead Technician
Seattle, WA  (Fred Hutchinson Cancer Research Center)

Director of Cell Therapy
New York, NY (New York Blood Center)

Marketing Assistant
Vancouver, BC (StemCell Technologies)

Post Doctoral Fellow
(enter Requisition Code 0408577) Somerville, New Jersey (Ethicon)

Principal/Senior Scientist
(enter Requisition Code 0408581)Somerville, New Jersey (Ethicon)

Product Manager (Immunology)
Vancouver, BC (StemCell Technologies)

Sales Representative
Vancouver, BC (StemSoft)

Scientist
(enter Requisition Code 0408593)- Somerville, New Jersey (Ethicon)

Senior Software Developer  
Vancouver, BC (StemSoft)

Stem Cell Specialist
Philadelphia, PA  (Children’s Hospital of Philadelphia)

Quality Control Technologist 
Vancouver, BC (StemCell Technologies)

ISCT’s Quality Assurance Group launches online discussion board to discuss Quality Management issues via open, honest discussion by experienced, interested parties.

Upcoming Meetings & Conferences:

2005 Cell Therapy Audioconference Series

May 3-4, 2005 Current Good Tissue Practice. Vancouver, BC
Workshop Chairs: Janice Davis-Sproul, MAS, MT (ASCP) SBB (John Hopkins University) & John McMannis, PhD (MD Anderson Cancer Center)
Email

May 4-7th, 2005 11th Annual ISCT Meeting. Vancouver, BC
Program Themes Include: Tissue Engineering, Mesenchymal Stem Cells, Immunotherapy, & Hematopoietic Stem Cells
Email

May 4-7th, 2005 Applications of Flow Cytometry in Marrow and Stem Cell Transplantation. Vancouver, BC
Email

Read Cytotherapy in 2005.  Join ISCT ($130) and receive the journal as a benefit of membership
http://www.celltherapy.org/mem_app.htm

Interested in Advertising in Cytotherapy?
For more information and advertising rates, Visit: http://www.celltherapy.org/journalrates.htm

Current Volume: Volume 6 Number 6/December 2004
Cytotherapy publishes original research, reviews, meeting reports, special focus issues and letters in the general field of cell therapy. The scope of the journal includes basic and applied research with hematopoietic and non-hematopoietic stem cells , immune cells, and antigen-presenting cells. Therapeutic topics within the scope of Cytotherapy include ex-vivo and in-vivo aspects of gene therapy, immunotherapy, stem cell transplantation and tissue regeneration. Cytotherapy particularly welcomes
contributions from researchers, clinicians, technicians and individuals involved in regulatory aspects of cell therapy.
www.cytotherapy.com